‘Autoreplication’ of the vector genome in recombinant adenoviral vectors with different E1 region deletions and transgenes

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Gene Therapy

• Publication date

  1999-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.gt.3300928PMID 10455413
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High adenoviral loads stimulate NFκB-dependent gene expression in human vascular smooth muscle cells

  1998cited by this paper
• Endogenous or overexpressed cGMP-dependent protein kinases inhibit cAMP-dependent renin release from rat isolated perfused kidney, microdissected glomeruli, and isolated juxtaglomerular cells.

  1998cited by this paper
• CFTR gene transduction in neonatal rabbits using anadeno-associated virus (AAV) vector

  1997cited by this paper
• Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression

  1997cited by this paper
• Persistence of recombinant adenovirus in vivo is not dependent on vector DNA replication

  1997cited by this paper
• ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

  1997cited by this paper
• Heterologous expression of adenovirus E3-gp19K in an E1a-deleted adenovirus vector inhibits MHC I expression in vitro, but does not prolong transgene expression in vivo

  1997cited by this paper
• cGMP Stimulation of Cystic Fibrosis Transmembrane Conductance Regulator Cl− Channels Co-expressed with cGMP-dependent Protein Kinase Type II but Not Type Iβ*

  1997cited by this paper
• An optimized protocol for mRNA quantification using nested competitive RT-PCR.

  1997cited by this paper
• Adeno-associated virus vectors for vascular gene delivery.

  1997cited by this paper
• Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression.

  1997cited by this paper
• Long-term gene expression from autonomously replicating vectors in mammalian cells.

  1996cited by this paper
• Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo

  1996cited by this paper
• Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo.

  1996cited by this paper
• Elimination of both E1 and E2 from adenovirus vectors further improves prospects for in vivo human gene therapy

  1996cited by this paper
• Towards the use of replicative adenoviral vectors for cancer gene therapy.

  1996cited by this paper
• Humoral and cellular immune responses of nonhuman primates to long-term repeated lung exposure to Ad2/CFTR-2.

  1996cited by this paper
• Engineering a mini-herpesvirus as a general strategy to transduce up to 180 kb of functional self-replicating human mini-chromosomes.

  1996cited by this paper
• Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.

  1996cited by this paper
• Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.

  1996cited by this paper
• Lack of persistence of E1- recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs.

  1996cited by this paper
• The Molecular Repertoire of Adenoviruses I

  1995cited by this paper
• Recombinant IL–12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung

  1995cited by this paper
• Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo.

  1995cited by this paper
• Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector.

  1995cited by this paper
• Long–term hepatic adenovirus–mediated gene expression in mice following CTLA4Ig administration

  1995cited by this paper
• Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.

  1994cited by this paper
• Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis

  1994cited by this paper
• Human artificial episomal chromosomes for cloning large DNA fragments in human cells

  1994cited by this paper
• MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.

  1994cited by this paper
• Assessment of Recombinant Adenoviral Vectors for Hepatic Gene Therapy

  1993cited by this paper
• Site-directed mutagenesis by overlap extension using the polymerase chain reaction.

  1989cited by this paper
• The adenovirus early proteins.

  1984cited by this paper
• Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection.

  1982cited by this paper

• Protein modification with ISG15 blocks coxsackievirus pathology by antiviral and metabolic reprogramming

  2020cites this paper
• Adenoviral Vector Vaccines Antigen Transgene

  2016influential citation
• Ubiquitin-Like Protein ISG15 (Interferon-Stimulated Gene of 15 kDa) in Host Defense Against Heart Failure in a Mouse Model of Virus-Induced Cardiomyopathy

  2014cites this paper
• Single-target RNA interference for the blockade of multiple interacting proinflammatory and profibrotic pathways in cardiac fibroblasts.

  2014cites this paper
• Adenovirus vector-mediated RNA interference for the inhibition of human parvovirus B19 replication.

  2013cites this paper
• Efficient Melanoma Cell Killing and Reduced Melanoma Growth in Mice by a Selective Replicating Adenovirus Armed with Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand

  2011cites this paper
• Tick salivary gland proteins (SALPs) as antigens for vaccine development to decrease spirochete load in a murine model of lyme borreliosis

  2010cites this paper
• Oncolytic adenovirus vectors for nitroreductase suicide gene therapy of prostate cancer

  2010cites this paper
• Efficient and selective tumor cell lysis and induction of apoptosis in melanoma cells by a conditional replication‐competent CD95L adenovirus

  2009cites this paper
• Prevention of Cardiac Dysfunction in Acute Coxsackievirus B3 Cardiomyopathy by Inducible Expression of a Soluble Coxsackievirus-Adenovirus Receptor

  2009cites this paper
• Extended transgene expression from a nonintegrating adenoviral vector containing retroviral elements.

  2008cites this paper
• Highly efficient and specific modulation of cardiac calcium homeostasis by adenovector-derived short hairpin RNA targeting phospholamban

  2007cites this paper
• Coxsackievirus B3 and adenovirus infections of cardiac cells are efficiently inhibited by vector-mediated RNA interference targeting their common receptor

  2007cites this paper
• A bidirectional Tet-dependent promotor construct regulating the expression of E1A for tight control of oncolytic adenovirus replication.

  2007cites this paper
• Tamoxifen-regulated adenoviral E1A chimeras for the control of tumor selective oncolytic adenovirus replication in vitro and in vivo

  2006cites this paper
• An improved Tet-On regulatable FasL-adenovirus vector system for lung cancer therapy

  2006cites this paper
• Viral and nonviral factors causing nonspecific replication of tumor- and tissue-specific promoter-dependent oncolytic adenoviruses.

  2005cites this paper
• Adenovirus vectors deleted for genes essential for viral DNA replication.

  2005cites this paper
• A novel tetracycline-controlled transactivator–transrepressor system enables external control of oncolytic adenovirus replication

  2003cites this paper
• Sarcoplasmic Reticulum Proteins as Potential Targets for Gene Therapy of Heart Failure

  2003cites this paper
• Production of helper‐dependent adenovirus vector relies on helper virus structure and complementing

  2002cites this paper
• Viral vector-mediated gene expression in olfactory ensheathing glia implants in the lesioned rat spinal cord

  2002cites this paper
• A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector.

  2001cites this paper
• This information is current as Lymphocytes Permits Adenovirus Infection of Primary Coxsackie / Adenovirus Receptor Transgene Expression of a Human

  2000cites this paper
• Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells

  2000cites this paper
• Expression of a Human Coxsackie/Adenovirus Receptor Transgene Permits Adenovirus Infection of Primary Lymphocytes1

  2000cites this paper